| detection of cytomegalovirus infection during clinical trials of glycoprotein b vaccine. | preabsorption of sera with cytomegalovirus (cmv) glycoprotein b (gb) prior to testing for cmv igg antibody was evaluated for detection of cmv infection during cmv gb vaccine clinical trials. although, 98.2% of 109 cmv gb vaccine recipients were seropositive with a standard assay, preabsorption of sera with gb reduced their cmv antibody to extremely low levels compared with subjects with cmv infection. one subject who acquired cmv during a vaccine trial was easily identified by gb-absorbed cmv ig ... | 2004 | 15530699 |